The data illustrate that several patients remained on zenocutuzumab well beyond progression, including multiple patients who continued treatment for more than one- or two-years post-progression.

DigitalXForce Secures $5M Strategic Investment, Hits $100M Valuation to Accelerate Global Expansion of AI-Powered GRC & Continuous Security Posture Management This funding is a strong vote of ...

As 2026 begins, these are the most anticipated video games on the horizon. From GTA 6 to Wolverine and beyond, here’s what ...

Please note: The event information above has been added by the organiser. Whilst we try to ensure all details are up-to-date we do not make any warranty or representation as to the accuracy or ...

IV treatment is one of the most traditionalist and wide-spread treatments provided to the 90% of hospitalised patients, yet, recent supply challenges like the Baxter IV fluids crisis have shown that ...

Intel stock surges 90%, see how Nvidia partnership, vPro upgrades, and ASP growth could offset INTC's margin pressures.

Discover the top 3 undervalued Health Care Equipment & Supplies stocks for Wednesday, December 31 based on AAII’s Stock ...

Research presented December 8 at the American Society of Hematology Conference in Florida, has shown that a new kind of CAR T-cell therapy, which generates CAR T-cells inside the body, could offer a ...

An online comment raised concerns about the randomisation scheme and allocation ratio in this cluster randomised study. There were discrepancies in the original data set for the cluster periods, which ...

Caroline Banton has 6+ years of experience as a writer of business and finance articles. She also writes biographies for Story Terrace. David Kindness is a Certified Public Accountant (CPA) and an ...